Your search returned 3 results.

Results
	1.	30-day readmission, antibiotics costs and costs of delay to adequate treatment of Enterobacteriaceae UTI, pneumonia, and sepsis: a retrospective cohort study. MedStar authors: Shorr, Andrew F PMID: 29225798 Year: 2017 Citation: Antimicrobial Resistance & Infection Control. 6:124, 2017 Institution: MedStar Washington Hospital Center Department: Medicine/Pulmonary-Critical Care Medline publication type: Journal Article Form of publication: Journal Article All authors: Fan W, Nathanson BH, Shorr AF, Sulham K, Zilberberg MD DOI: https://dx.doi.org/10.1186/s13756-017-0286-9 Add to cart (remove)
	2.	Secular trends in gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000-2009. MedStar authors: Shorr, Andrew F PMID: 23917908 Year: 2013 Citation: Infection Control & Hospital Epidemiology. 34(9):940-6, 2013 Sep. Institution: MedStar Washington Hospital Center Department: Medicine/Pulmonary-Critical Care Medline publication type: Journal Article Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Shorr AF, Zilberberg MD DOI: http://dx.doi.org/10.1086/671740 Add to cart (remove)
	3.	Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis. MedStar authors: Shorr, Andrew F PMID: 28415969 Year: 2017 Citation: BMC Infectious Diseases. 17(1):279, 2017 Apr 17 Institution: MedStar Washington Hospital Center Department: Medicine/Pulmonary-Critical Care Medline publication type: Journal Article Form of publication: Journal Article All authors: Fan W, Nathanson BH, Shorr AF, Sulham K, Zilberberg MD DOI: https://dx.doi.org/10.1186/s12879-017-2383-z Add to cart (remove)

Powered by Koha